Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Duruisseaux

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Revue Des Maladies Respiratoires|July 29, 2025
[Autoimmune diseases and immunotherapies]A Mogenet, M Duruisseaux, B Grigoriu, et al.
Respiratory Medicine and Research|June 9, 2020
Do systemic treatments delivered after Nivolumab result in better outcomes? A bicentric case-control studyM Darrason, E Chatelain, F Ranchon, et al.
Bulletin Du Cancer|April 2, 2010
Influenza vaccination in patients with haematologic malignancies: analysis of practices in 200 patients in a single centerF Lachenal, C Sebban, M Duruisseaux, et al.
Gynecologie, Obstetrique & Fertilite|July 10, 2012
[Regional recurrence of triple-negative breast cancer: interest of systematic adjuvant lymph node irradiation?]J Clerc, M-P Sunyach, M Duruisseaux, et al.
Revue Des Maladies Respiratoires|January 28, 2014
[Residents in respiratory medicine: Assessment of the course and wishes regarding their career]M Patout, H Salvator, S Korzeniewski, et al.
Respiratory Medicine and Research|January 14, 2020
Impact of systematic advanced care planning in lung cancer patients: A prospective studyN Denis, J-F Timsit, M Giaj Levra, et al.
Lung Cancer (Amsterdam, Netherlands)|November 17, 2012
Clinical and molecular features in patients with advanced non-small-cell lung carcinoma refractory to first-line platinum-based chemotherapyE Giroux Leprieur, M Antoine, T Vieira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2020
NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agentsJ Laskin, S V Liu, K Tolba, et al.
Respiratory Medicine and Research|June 22, 2020
Proposals for managing patients with thoracic malignancies during COVID-19 pandemicN Girard, L Greillier, G Zalcman, et al.
Journal of Bone Oncology|June 21, 2021
Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinomaE Massy, J C Rousseau, M Gueye, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Revue Des Maladies Respiratoires|July 29, 2025
[Autoimmune diseases and immunotherapies]A Mogenet, M Duruisseaux, B Grigoriu, et al.
Respiratory Medicine and Research|June 9, 2020
Do systemic treatments delivered after Nivolumab result in better outcomes? A bicentric case-control studyM Darrason, E Chatelain, F Ranchon, et al.
Bulletin Du Cancer|April 2, 2010
Influenza vaccination in patients with haematologic malignancies: analysis of practices in 200 patients in a single centerF Lachenal, C Sebban, M Duruisseaux, et al.
Gynecologie, Obstetrique & Fertilite|July 10, 2012
[Regional recurrence of triple-negative breast cancer: interest of systematic adjuvant lymph node irradiation?]J Clerc, M-P Sunyach, M Duruisseaux, et al.
Revue Des Maladies Respiratoires|January 28, 2014
[Residents in respiratory medicine: Assessment of the course and wishes regarding their career]M Patout, H Salvator, S Korzeniewski, et al.
Respiratory Medicine and Research|January 14, 2020
Impact of systematic advanced care planning in lung cancer patients: A prospective studyN Denis, J-F Timsit, M Giaj Levra, et al.
Lung Cancer (Amsterdam, Netherlands)|November 17, 2012
Clinical and molecular features in patients with advanced non-small-cell lung carcinoma refractory to first-line platinum-based chemotherapyE Giroux Leprieur, M Antoine, T Vieira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2020
NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agentsJ Laskin, S V Liu, K Tolba, et al.
Respiratory Medicine and Research|June 22, 2020
Proposals for managing patients with thoracic malignancies during COVID-19 pandemicN Girard, L Greillier, G Zalcman, et al.
Journal of Bone Oncology|June 21, 2021
Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinomaE Massy, J C Rousseau, M Gueye, et al.
Pageof 2